Nihon Kohden
Nihon Kohden Corporation, a leading name in the medical technology industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and the Americas. Founded in 1951, the company has established itself as a pioneer in the development of innovative medical devices and solutions, particularly in the fields of patient monitoring, electrophysiology, and neurodiagnostics. Nihon Kohden's core products include advanced patient monitors, electrocardiographs, and EEG systems, all designed to enhance clinical efficiency and patient care. The company is renowned for its commitment to quality and innovation, which has earned it a strong market position and numerous accolades within the healthcare sector. With a focus on integrating cutting-edge technology and user-friendly design, Nihon Kohden continues to set benchmarks in medical instrumentation, making significant contributions to global healthcare advancements.
DitchCarbon Score
How does Nihon Kohden's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nihon Kohden's score of 43 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nihon Kohden's reported carbon emissions
In 2023, Nihon Kohden reported total carbon emissions of approximately 7,894,000 kg CO2e, with Scope 1 emissions at about 4,250,000 kg CO2e and Scope 2 emissions at around 3,644,000 kg CO2e. This marks a significant reduction from previous years, as emissions in 2022 were approximately 9,367,000 kg CO2e, and in 2021, they were about 10,171,000 kg CO2e. The company has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. The absence of Scope 3 emissions data in 2023 indicates a potential area for future reporting and improvement. Overall, Nihon Kohden's emissions have decreased consistently over the past few years, reflecting a proactive approach to climate responsibility within the medical technology industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 4,684,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 7,610,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 12,294,000 | 00,000,000 | 0,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nihon Kohden is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
